Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation

摘要

BackgroundDual antiplatelet treatment (DAPLT) for at least 12 months is recommended after drug eluting stent (DES) implantation, but concerns regarding the extended use of this treatment persist due to increased risk of bleeding. In this study are assessed the incidence, correlates, and clinical significance of bleeding complications in diabetic patients after long-term DAPLT post DES implantation.